Reaction

Immunosuppressant Drug Level Decreased reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,175 reports · 49 co-occurring drugs

As of the last recalculation, Immunosuppressant Drug Level Decreased appears in 1,175 FAERS reports alongside 49 co-occurring drug terms. The strongest observed disproportionality signal is TACROLIMUS (PRR 260.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Tacrolimus780260.4261.7
Tacrolimus Extended-Release Capsules522132.5133.0
Tacrolimus Ointment 0.1%513128.7129.3
Everolimus Tablets7584.684.9
Basiliximab4672.172.3
Mycophenolate Mofetil34964.364.5
Mycophenolate Mofetil Hydrochloride34964.264.4
Pyrazinamide3058.058.2
Rifampicin3155.755.9
Valganciclovir Hydrochloride Powder,3146.246.3
Mycophenolic Acid6940.540.6
Rifampin3239.940.0
Valganciclovir4139.940.0
Valganciclovir Hydrochloride4139.940.0
Cyclosporine18133.933.9
Mycophenilic Acid3732.632.7
Oseltamivir1431.531.6
Isoniazid2730.230.2
Everolimus7829.029.1
Anti-Thymocyte Globulin (Rabbit)1328.928.9
Sirolimus1824.024.1
Prednisolone19923.323.3
Prednisolone Oral19923.323.3
Prednisolone Oral Solution19923.323.3
Voriconazole Injection2420.020.0
Micafungin Sodium918.919.0
Voriconazole3017.917.9
Amikacin1616.816.8
Azathioprine7516.016.1
Ketoconazole Foam1214.514.5
Ketoconazole Cream, 2%1214.514.5
Meropenem2413.513.5
Calcitriol Capsules 0.25 Mcg1412.512.5
Calcitriol Capsules 0.5 Mcg1412.512.5
Ketoconazole1212.412.4
Calcitriol1412.412.4
Insulin Glargine-Yfgn1512.312.3
Itraconazole812.212.2
Piperacillin Sodium,Tazobactam Sodium1812.212.2
Ganciclovir712.212.2
Ganciclovir Sodium711.811.8
Oseltamivir Phosphate1511.011.0
Ritonavir 100 Mg89.59.5
Entecavir69.19.1
Ledipasvir And Sofosbuvir98.38.4
Lumacaftor And Ivacaftor48.38.3
Tenofovir Disoproxil Fumarate Tablets48.28.2
Sofosbuvir65.45.4
Elexacaftor, Tezacaftor, And Ivacaftor34.34.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.